Nashville-based Revance Therapeutics saw its stock price plummet by almost 40 percent Friday following the company's third ...

Revance on Tuesday said Crown now has until Nov. 19 to begin its $6.66-a-share tender offer for the Nashville, Tenn., biotechnology company. The latest extension comes after Revance last week warned ...

Revance Therapeutics ... Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.

Here is a breakdown of the information Revance Therapeutics presented to its investors. Revance Therapeutics, Inc., a biotechnology company headquartered in Nashville, Tennessee, is known for its ...

For three-and-a-half decades, we here at the Nashville Scene have done our best to share with our readers what makes Music City special. That’s the aim every week, of course, but most of all in ...

NASHVILLE, TN - Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology firm specializing in pharmaceutical preparations, announced on Friday an extension to the commencement date of a tender ...

Join our team in Nashville. At UBS Nashville, we pride ourselves on our commitment to collaboration, innovation, and growth. With an office culture second to none, we provide a supportive community ...

The best time to visit Nashville is from April through October, when the warm weather brings this music city to life. Although December is quite charming with Christmas decorations at the Opryland ...

NASHVILLE, TN - Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology firm specializing in pharmaceutical preparations, announced on Friday an extension to the commencement date of a tender offer ...